Mosapride Citrate

枸橼酸莫沙必利

Report date: 2024/03/26 11:57:36
NME

Base Information

Drug NameMosapride Citrate
Drug Alias Namemosapride莫沙必利枸橼酸盐Mosafe莫沙比利枸橼酸盐枸橼酸莫沙比利 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsEnteral Feeding IntoleranceDyspepsiaConstipation +[5] 
Global Approved IndicationsGastritis
Approved Indications in ChinaGastritis
Original Approved Country/TerritoryJapan
Original Approved Date1998/06/30
Country/TerritoryEgyptLebanonSouth Korea +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDainippon Sumitomo Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDainippon Sumitomo Pharma Co LtdAin Shams University
Inactive CompaniesGlaxosmithkline PlcDaewoong Pharmaceutical Co LtdHuazhong University Of Science And Technology +[4] 
Active IndicationsEnteral Feeding IntoleranceGastritis
Inactive IndicationsDyspepsiaConstipationIrritable Bowel Syndrome

Other Information

ATC CodeA03FA09
Related LinksWikipediaKEGG